Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR Cause Visual impairment? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Visual impairment have been filed in association with DOLUTEGRAVIR (Juluca). This represents 0.2% of all adverse event reports for DOLUTEGRAVIR.

20
Reports of Visual impairment with DOLUTEGRAVIR
0.2%
of all DOLUTEGRAVIR reports
0
Deaths
6
Hospitalizations

How Dangerous Is Visual impairment From DOLUTEGRAVIR?

Of the 20 reports, 6 (30.0%) required hospitalization, and 2 (10.0%) were considered life-threatening.

Is Visual impairment Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does DOLUTEGRAVIR Cause?

Foetal exposure during pregnancy (1,036) Exposure during pregnancy (776) Virologic failure (770) Pathogen resistance (586) Maternal exposure during pregnancy (517) Viral mutation identified (510) Treatment failure (453) Drug ineffective (447) Off label use (413) Blood hiv rna increased (410)

What Other Drugs Cause Visual impairment?

INSULIN GLARGINE (5,793) INSULIN LISPRO (4,654) ADALIMUMAB (3,770) DUPILUMAB (3,089) ETANERCEPT (2,489) FINGOLIMOD (2,147) AFLIBERCEPT (1,836) PREGABALIN (1,714) METHOTREXATE (1,588) TOFACITINIB (1,544)

Which DOLUTEGRAVIR Alternatives Have Lower Visual impairment Risk?

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE DOLUTEGRAVIR vs DOMPERIDONE DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE

Related Pages

DOLUTEGRAVIR Full Profile All Visual impairment Reports All Drugs Causing Visual impairment DOLUTEGRAVIR Demographics